Evidence-based management of schizophrenia
- 1 April 2004
- journal article
- review article
- Published by Mark Allen Group in Hospital Medicine
- Vol. 65 (4) , 201-205
- https://doi.org/10.12968/hosp.2004.65.4.12731
Abstract
Antipsychotic medication is the foundation of care for patients who suffer from schizophrenia and other psychotic conditions. Newly diagnosed patients should be treated with atypical antipsychotics, of which the National Institute for Clinical Excellence guidelines recommend five. The quality of clinical evidence will ultimately establish the differences between available treatments.Keywords
This publication has 19 references indexed in Scilit:
- The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitmentActa Psychiatrica Scandinavica, 2003
- AripiprazoleCNS Drugs, 2002
- Good tolerability equals good results: the patient’s perspectiveEuropean Neuropsychopharmacology, 2001
- Atypical Antipsychotics: New Directions and New Challenges in the Treatment of SchizophreniaAnnual Review of Medicine, 2001
- The new generation of antipsychotic drugs: how atypical are they?International Journal of Neuropsychopharmacology, 2000
- Effectiveness of Antipsychotic Therapy in a Naturalistic SettingThe Journal of Clinical Psychiatry, 1999
- DA7 Prospective, Naturalistic Outcomes Measurement: The Schizophrenia Care And Assessment Program (SCAP)Value in Health, 1998
- The Course of Schizophrenia Over 13 YearsThe British Journal of Psychiatry, 1996
- Conventional Antipsychotic Medications for SchizophreniaSchizophrenia Bulletin, 1995
- Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United StatesNew England Journal of Medicine, 1993